Dey Indranil's Form 4/A amendment
AmendedBluejay Diagnostics, Inc. (BJDX) · filed Mar 31, 2023
- Accession no.
- 0001213900-23-025243
- Filed
- Mar 31, 2023, 1:45 PM ET
- Trade date
- Mar 27-28, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 28, 2023
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.40K. It was filed 4 days after the trade.
This amendment replaces 0001213900-23-023546 (filed Mar 28, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dey IndranilCIK 0001889815 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | PPurchaseAcquired | +8,000 | $0.44 | +$3,520 | 558,538 | Direct | |
| Mar 28, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $0.44 | +$880 | 660,538 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.